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Abstract 
Patients with any major illness can expect to experience uncertainty about the nature of their illness, 
its treatment, and their prognosis. Prognostic uncertainty is a particular source of patient distress 
among those living with life limiting disease. Uncertainty also affects professionals and it has been 
argued that the level of professional tolerance of uncertainty can affect levels of investigation as well 
as healthcare resource use.  
We know that the way in which uncertainty is recognised, managed and communicated can have 
important impacts on patients’ treatment and quality of life. Current approaches to uncertainty in 
life limiting illness include the use of care bundles and approaches that focus on communication and 
education. The experience in communicating in difficult situations that specialist palliative care 
professionals can provide may also be of benefit for patients with life limiting illness in the context of 
uncertainty.  
Whilst there are a number of promising approaches to uncertainty, as yet few interventions targeted 
at recognising and addressing uncertainty have been fully evaluated and further research is needed 
in this area. 
 
 
 
 
 
 
 
 
 
 
 
Main Messages: 
 Uncertainty will always be present in life limiting illness, and if poorly recognised and 
managed, can impact adversely on patient outcomes.  
 When managing uncertainty, professionals should consider what their patients’ may 
prioritise in situations of uncertainty. 
 Interventions exist to assist in the management of uncertainty, but need further 
evaluation. Promotion of communication between patients and professionals, education 
interventions, and integration of palliative care are promising approaches.  
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Introduction 
William Osler is quoted as saying medicine is the science of uncertainty.(1)  Following this 
uncertainty has and will probably always remain a key aspect of medicine. Despite advances in 
medicine over the past century, uncertainty prevails alongside illness. As diagnostic tests, treatments 
and the healthcare system itself become ever more complex, patients, with any major illness, can 
expect to experience a great deal of uncertainty about the nature of their illness, its treatment, and 
their prognosis.   
Clinicians too experience uncertainty every day.  A major part of the doctor’s role is to assess and 
manage uncertainty in terms of the risk/benefit of deciding to operate on a patient, the value of 
investigating and then managing a symptom in a patient with limited prognosis, or in responding to 
patients’ difficult questions. 
All of these uncertainties can be present in life limiting illness. However, prognostic uncertainty is an 
additional source of patient and professional distress among those living with life limiting disease. 
The age old question ‘how long have I got, doctor?’ is one that many still struggle to answer. This 
article therefore aims to examine in detail the concept of uncertainty in illness; and its impact on 
patients and professionals. We then appraise current practice and evidence in addressing 
uncertainty in life limiting illness, and suggest an ideal approach.  
 
What is uncertainty in illness? 
Uncertainty is not a simple or easily defined concept and a situation of uncertainty usually results 
from several inter-related factors. Mishel  was one of the first researchers to develop an overarching 
theory of uncertainty in illness which aimed to explain the underlying processes governing patients’ 
experiences of uncertainty.(2) She identified four concepts that contributed to an uncertain state– 
complexity, unpredictability, ambiguity, and lack of information.(2-4) In her concept analysis of 
uncertainty in illness, McCormick further developed these ideas and described situations of 
uncertainty in terms of the probability of events occurring, the temporality of events, and 
individuals’ perceptions of their situation.(5)  (See figure 1) 
Any given situation of uncertainty may be made up of several of these factors, but equally, there are 
many forms of uncertainty in healthcare.(6) In her discussion of uncertainty as applied to the 
primary care consultation,  Greenhalgh defined 4 broad areas: uncertainty regarding the illness itself 
& the evidence base; uncertainty about a patient’s story; uncertainty about what best to do for a 
patient; and the uncertainty of multi-professional collaborative care(7). A key point to add to this 
taxonomy is that patients and clinicians may understand and appraise uncertainty differently – some 
uncertainties are patient driven, and others are professional.  
Research contributions have considered healthcare professional responses to uncertainty over a 50- 
year timescale.(8, 9) Earlier research focused on the ways in which professionals ‘cover’ uncertainty 
to present a definite plan.  For example, one paper noted that ‘physicians to be’ were ‘trained for 
control’ rather than trained for uncertainty.(10) More recent research has examined health care 
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professionals’ engagement with uncertainty and the impacts of uncertainty on professionals and 
patients.(11) (See also later section)   
<FIGURE 1 HERE> 
 
The additional uncertainties of advanced life-limiting illness.  
At all stages of life-limiting illness, the difficulty in predicting prognosis represents an additional 
source of uncertainty.(13)  A growing body of research has been undertaken into the illness 
trajectory and prognostication in life-limiting illness, yet some degree of prognostic uncertainty 
usually remains, even when life expectancy is short.(14, 15)  
Despite this we know a lot about prognosis and illness trajectories. We know that the trajectory of 
decline in terminal cancer is different to that of organ failure, different to renal failure, and different 
again to frailty and dementia.(16-18) We can also identify poor prognostic features of many 
illnesses, and in some situations, very well validated scores (such as, for example, the APACHE 2 
score (19)) exist to help predict outcome.  But the task of prognostication has its limits and analysis 
has demonstrated that a proportion of deaths are sudden and unexpected.(20) Prognostication 
remains difficult in the last 6 months of life: A review of prognostic indicators found that they have 
insufficient sensitivity or specificity when predicting prognoses shorter than 6 months in non-
cancer.(21, 22)  A study of 149 deaths on medical wards in an acute hospital identified that 38% of 
deaths weren’t expected on admission – they either occurred suddenly, or following an 
unpredictable dying trajectory.(23) Another study of prognostication by expert clinicians observed 
only one out of every five prognostic estimates was within 33% of actual survival (n=).(13, 24) Whilst 
prognostication may be refined further in the future, it remains to some extent an art rather than a 
science,(25) and prognostic uncertainty is likely to remain a common feature in advanced illness.  
Some early approaches in the uncertainty literature argued that the clinician’s role is to reduce or 
remove uncertainty,(8, 10, 26, 27) but it is now considered that as an abstract concept, uncertainty 
is neutral cognitive state. (28, 29)  It is rather the appraisal of uncertainty that can lead to its 
protective or harmful effects. Mishel acknowledged that uncertainty can be experienced positively 
as ‘opportunity’ or negatively as ‘danger,’ but also suggested that the role of ‘structure providers’, 
including clinicians, is to reduce uncertainty.(4) (See figure 2)  
<FIGURE 2 HERE> 
As we have seen, elimination of uncertainty in advanced illness is unlikely to be achievable. It is also 
known that some patients hold on to uncertainty in a protective manner to shield themselves from a 
poor prognosis,(30)  and that over-expression of uncertainty can lead to poorer decision satisfaction 
for patients.(31) Knowing this, it is clear that any approach to uncertainty needs to be nuanced and 
patient specific, particularly because the level of uncertainty experienced in advanced illness is likely 
to fluctuate over time. (11, 32, 33)  
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Why does uncertainty matter? How does it impact on patients, families and professionals? 
Uncertainty matters because it affects patients with life-limiting illness, their family & carers at a 
profoundly emotional level.(32)   Qualitative studies of patient experiences in a wide range of 
illnesses including cancer, heart failure, chronic lung disease, multimorbidity, and hospital inpatients 
have elucidated that uncertainty significantly impacts on patients’ lives. (34-39) Patients who are 
uncertain about their futures can become preoccupied with this uncertainty and sometimes 
overwhelmed to the extent that their sense of self is impacted.(40) A majority of patients wish to 
discuss this uncertainty.(41, 42). Research suggests this rarely happens. (43)  
It has been shown that if uncertainty is not appropriately addressed this can result in worse 
psychological outcomes for patients.(44-46). Uncertainty is linked to anxiety in its association with 
fear of the future.(44, 47) There are additional potential impacts on the patient-professional 
relationship if uncertainty is imperfectly expressed; Politi et al found that greater communication of 
clinician uncertainty during decision making about breast cancer treatment led to poorer decision 
satisfaction for patients.(31)   Blanch et al found that medical students who make more expressions 
of uncertainty during their interactions with patients are less well regarded.(48) 
Uncertainty also impacts on clinician’s practice and their confidence; clinicians frequently struggle 
with uncertainty which can result in overtreatment or over-investigation,(49) increased costs,(45, 
50) and lack of communication with patients about their future.(51, 52) Some have gone further 
than this, arguing that intolerance of uncertainty is leading to a culture of chronic disease where 
every abnormality is classified as pathology.(53) Further, it could be argued that training for 
clinicians to manage uncertainty is lacking – less than 20% of current UK postgraduate medical 
training curricula contain detailed recommendations and curriculum goals relevant to dealing with 
uncertainty.(54)  
It is not possible to eliminate prognostic or other uncertainty in life limiting illness, and so a 
paradigm focused purely on uncertainty reduction is inappropriate.(32) But as we have shown, 
unrecognised or poorly addressed uncertainty can lead to negative patient and healthcare 
outcomes. It is therefore paramount to appropriately address uncertainty in patients with life 
limiting illness. The complexity of the concept means that an individualised and nuanced approach is 
likely to be most beneficial.(55) 
 
Addressing uncertainty: current strategies. 
There is a range of current practice in addressing uncertainty in life-limiting illness, but three main 
approaches are evident. 
1. Disengagement or minimisation of uncertainty –Evidence indicates that uncertainty is commonly 
either unrecognised or recognised and unaddressed.(51) Systematic reviews of communication 
in Chronic Obstructive Pulmonary Disease (COPD) and heart failure observed that discussions of 
end of life care (EOLC ) and prognosis rarely occurred (41, 56). Multiple barriers to discussion of 
prognosis in advanced illness are evident including; lack of time, lack of expertise, fear of taking 
away hope by removing protective uncertainty, disagreement within teams about the level of 
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disclosure(41, 42) and perhaps this accounts for why in many settings uncertainty remains 
underserved. 
 
2. The care bundle approach – In the hospital setting, tools such as the AMBER care bundle, or the 
Psychosocial Assessment and Communication Evaluation tool (PACE) have been developed with 
the intention to aid recognition and management of clinically uncertainty situations.(57, 58) The 
AMBER care bundle was developed for patients who are deteriorating, with uncertain recovery 
and who are at risk of dying in the next 1 – 2 months. (57) It comprises an identification phase, 
followed by the development of a clear medical plan for patients identified as fulfilling the 
criteria in conjunction with the patient and their family. The individual patient-centred plan is 
then reviewed daily. The care bundle, which includes roles for the entire medical team 
emphasises clear communication and planning. This approach is promising and recent research 
suggests that there may be some benefits; awareness of prognosis appeared to be higher 
among patients supported by the AMBER care bundle.(35) However a full evaluation of the 
efficacy of this approach is needed.  Moreover, a recent single centre study identified that rather 
than being used as a tool to identify patients with an uncertain recovery, the care bundle was 
principally used when it became certain that patients would not recover.(23) 
 
3. Education/Communication approach – Communication is key to all patient interaction and this is 
no different when addressing uncertainty.  Approaches thus far have focused either on patient 
education or training of healthcare professionals. Cognitive behavioural therapy based 
interventions directed at patients to improve their resilience and ability to cope with uncertainty 
have shown some success.(59, 60) Related are patient activation interventions aimed at 
encouraging patients to engage more closely with long term illness, though there is less 
evidence in advanced or life limiting disease.(61) Others have suggested the use of mindfulness 
based practice, a way of self-reflection in the present moment,(62) as a possible helpful tool in 
changing how uncertainty is appraised by patients, though as yet little empirical evidence 
supports the use of mindfulness in this context.(44, 63) 
 
Education of health professionals to cope better with & communicate more effectively the 
uncertainties of advanced illness is the other approach. This is consistent with the suggestion 
that all healthcare professionals dealing with patients with advanced life limiting disease are 
providing ‘generalist palliative care’, whilst specialist palliative care providers have a role in 
supporting other professionals in providing this care.(64) Courses such as the Sage and Thyme 
approach(65) or Transforming End of Life Care(66) provide multidisciplinary training for non-
specialist staff in communication, holding difficult conversations and dealing with clinical 
uncertainty in life limiting illness.  Other disease specific training programmes focused on 
communication have shown to aid discussion of prognosis and preferences for end of life care in 
COPD,(67) and to alter interview style for physicians.(68) These programmes may empower 
health professionals to recognise and address uncertainty in life limiting illness. All warrant 
evaluative scrutiny.  
 
7 
 
Addressing Uncertainty – the way forward? 
Whilst several different approaches exist to manage uncertainty in life limiting illness, there is not 
sufficient evidence to identify a ‘best method’. There is evidence that if addressed poorly or 
unaddressed, uncertainty is detrimental to patient and family care, but there is little evidence 
supporting the use of any of the approaches outlined above, and no comparative studies exist. 
Further research and evaluation of these approaches is needed.  In the meantime, there are some 
principles which can guide our approach.  
 
First, the way in which patients’ understand and process uncertainty is key to its impact. In some 
situations, uncertainty may be maintained for its protective effect (e.g. not seeking to find out about 
prognosis to avoid bad news), but in others it may have deleterious effects (e.g. when waiting for a 
potentially life-threatening diagnosis). Any approach to uncertainty therefore needs to take an 
individual view based on the situation and a patient’s experience. To date, no approach has done 
so. Ongoing unpublished qualitative research suggests that patients’ response to uncertainty in life 
limiting illness may usually be explained by three main factors, and perhaps it is these that should 
form the basis of future uncertainty-addressing interventions: 1. Level of engagement with illness 
and treatment, 2. Information needs and preferences & 3. Temporal focus (present or future).  
Second, uncertainty is experienced differently and at different times by patients and professionals. 
Patient-professional differences in experience and understanding of uncertainty can be expected to 
result in differences in agendas, and increase the risk of patients’ concerns going unaddressed (as 
has been noted in other settings(69)). Interventions addressing uncertainty by targeting this patient-
professional gap might be expected to improve outcomes. (Figure 3) 
<FIGURE 3 HERE> 
 
Third, evidence indicates that careful discussion with all stakeholders is needed to ensure the best 
communication of prognosis and prognostic uncertainty, especially in complex situations.(70) Poor 
communication was a major failing identified by the report into the use (and misuse) of the Liverpool 
Care Pathway.(71)  Research indicates that careful communication regarding prognosis can be 
beneficial in life limiting illness.(72) It is therefore reasonable to expect that the additional support 
and experience in communicating in difficult situations that specialist palliative care professionals 
can provide may lead to benefits for patients with life limiting illness in the context of uncertainty. 
By prioritising clear communication and care planning, the palliative care approach is promising in 
providing support for patients with life limiting illness experiencing uncertainty, and is worth 
evaluating in this context. 
 
Conclusion: 
Clinicians can, and should not eliminate uncertainty in life limiting illness. Nor is it their role to 
blindly discuss all uncertainties with every patient. But uncertainty, particularly prognostic 
uncertainty, requires greater thought and should be more frequently considered in order to achieve 
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the best outcomes for patients with life limiting illness and their families. Appropriate 
communication in these often complex situations is paramount. There is scope for care bundle-
based or education-based interventions to provide benefit although these require rigorous 
evaluations.  In addition, the palliative care approach promotes in depth individual assessment of 
each patient’s concerns, and this is potentially very helpful to the process of addressing uncertainty. 
Further research in this area is needed to evaluate the impact of existing approaches and those in 
development. 
 
 
 
 
Current Research Questions: 
 Do currently used interventions targeted at addressing uncertainty improve outcomes for 
patients? 
 What is the longer term impact of ‘protective uncertainty’ on patient outcomes, and 
should this uncertainty ever be challenged? 
 Can the use of the palliative care approach itself affect outcomes in the context of 
uncertainty?  
 How can palliative care be integrated into care for patients with lif limiting illness and 
uncertain prognosis? 
True False Questions 
 Prognostic uncertainty should always be discussed with patients with life limiting disease. 
True/False  
Answer: false – this depends on the individual patient’s communication preferences 
 Care bundles have been shown to improve quality of life in situations of uncertainty. 
True/False  
Answer: False – further evaluation is needed, though some care bundles show promising 
effects in preliminary evaluation. 
 Any approach to uncertainty needs to be patient specific and depends on patients’ level 
of engagement with their illness. True/False  
Answer: True 
 Patients with COPD and Heart failure have similar end of life disease trajectories. 
True/False  
Answer: True – patients with COPD and heart failure tend to follow a similar illness 
trajectory with exacerbations and remissions. 
 Professionals’ recognition and management of uncertainty has potentially large cost 
implications. True/False  
Answer: True – there is some evidence that intolerance of uncertainty affects ordering of 
investigations, and healthcare cost 
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Figure Legends: 
 
Figure 1: Terms associated with uncertainty in illness. (Adapted from Mishel and McCormick and as 
defined by Barber 1998)(4, 5, 12) 
 
Figure 2: Mishel’s model of perceived uncertainty in illness (reproduced with permission) 
 
 
Figure 3: patient/professional interaction in situations of uncertainty. A) patient- professional 
communication gap present with no cross communication of agendas. B) theoretical effect of an 
intervention to close communication gap 
